Amgen’s Restrictive 340B Policy
Amgen’s Restrictive 340B Policy – 10-16-2025 On September 2, RWC-340B sent a letter to Amgen’s CEO objecting to Amgen’s unilateral decision to refuse to honor 340B pricing for STD clinics. The Policy: Amgen…
Fighting to Preserve the Benefits of the 340B Program
Amgen’s Restrictive 340B Policy – 10-16-2025 On September 2, RWC-340B sent a letter to Amgen’s CEO objecting to Amgen’s unilateral decision to refuse to honor 340B pricing for STD clinics. The Policy: Amgen…
CMS Proposed Rule on 2026 Physician Fee Schedule – 10-16-2025 On September 12, RWC-340B submitted comments to CMS regarding its proposed methodology for excluding 340B drug prices from Medicare Part D inflation…